Business Description
Sutro Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US8693671021
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.17 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | -0.58 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.3 | |||||
Beneish M-Score | -0.04 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.9 | |||||
3-Year EBITDA Growth Rate | -9.8 | |||||
3-Year EPS without NRI Growth Rate | 0.2 | |||||
3-Year FCF Growth Rate | 5.7 | |||||
3-Year Book Growth Rate | -30.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | -12.88 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 81.34 | |||||
9-Day RSI | 65.37 | |||||
14-Day RSI | 57.42 | |||||
6-1 Month Momentum % | 84.17 | |||||
12-1 Month Momentum % | -10.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.5 | |||||
Quick Ratio | 4.5 | |||||
Cash Ratio | 4.01 | |||||
Days Sales Outstanding | 37.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | 0.57 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -58.07 | |||||
Net Margin % | -69.47 | |||||
FCF Margin % | -76.44 | |||||
ROE % | -65.18 | |||||
ROA % | -25.04 | |||||
ROIC % | -106.11 | |||||
ROC (Joel Greenblatt) % | -134.68 | |||||
ROCE % | -18.3 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.69 | |||||
PB Ratio | 1.74 | |||||
Price-to-Tangible-Book | 1.74 | |||||
EV-to-EBIT | -0.12 | |||||
EV-to-EBITDA | -0.14 | |||||
EV-to-Revenue | 0.05 | |||||
EV-to-Forward-Revenue | 0.09 | |||||
EV-to-FCF | -0.07 | |||||
Price-to-Net-Current-Asset-Value | 2.59 | |||||
Price-to-Net-Cash | 4.83 | |||||
Earnings Yield (Greenblatt) % | -833.33 | |||||
FCF Yield % | -33.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sutro Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 141.588 | ||
EPS (TTM) (€) | -1.667 | ||
Beta | 1.76 | ||
Volatility % | 105.48 | ||
14-Day RSI | 57.42 | ||
14-Day ATR (€) | 0.190064 | ||
20-Day SMA (€) | 3.554 | ||
12-1 Month Momentum % | -10.16 | ||
52-Week Range (€) | 1.9 - 5.45 | ||
Shares Outstanding (Mil) | 81.76 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sutro Biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sutro Biopharma Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Sutro Biopharma Inc Frequently Asked Questions
What is Sutro Biopharma Inc(STU:S09)'s stock price today?
When is next earnings date of Sutro Biopharma Inc(STU:S09)?
Does Sutro Biopharma Inc(STU:S09) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |